To those who have been involved in glioblastoma research in the past, I am sure that you understand the basics. For those who do now know, what you should know is that gliomas are looked at in the medical field as some of the most common tumors in the brain as well as the most aggressive seen. As a result, research efforts are made with them being seen at the center. With so much work to be done, I feel as though gene mutations and relations alike are going to be focused on.
BioNews Texas put together an article in reference to the various findings that have been connected to the field of glioblastoma multiforme. The report stated that, in 2013, there is an expected statistic of 23,000 cases of this condition to be seen. In addition, there seems to be a 15-month diagnosis for each new patient .Taking this kind of information into account, it's no secret that work is going to be done but what is it that researchers have been able to find as a result of such work?
Lynda Chin, M.D., professor and chair of the Cancer Genome Atlas, spoke about the findings that came after a five-year scientific sojourn. There has been comprehensive data depicting how the sojourn in question has been able to lend credence to the idea of new data. Information on genetic mutations, deletions, and amplifications were all found and it is very telling, if you ask me. To me, it goes to show that there is more to be found in terms of creating stronger therapies in the long term.
It isn't, as if, there weren't mutated genes discovered in the past and organizations like Voices against Brain Cancer can tell you the same about the matter. Keep in mind that those involved in glioblastoma research have been able to see, according to the article, 61 new mutated genes. There have been strong cases of the epidermal growth factor receptor on chromosome 7. The fact that the EGFR gene is mutated in 57% of tumors only adds to the amount of information found at this point.
Considering all of the work that has been seen glioblastoma research so far, it's clear that these particular tumors have been given tremendous attention. They are some of the most complicated growths you can imagine and they are going to vary in many ways from one patient to the next. The ability to pinpoint certain genes, though, can lend a greater assist to the methods conducted in the way of research. My only hope is that this kind of information will make therapies in place even better.
BioNews Texas put together an article in reference to the various findings that have been connected to the field of glioblastoma multiforme. The report stated that, in 2013, there is an expected statistic of 23,000 cases of this condition to be seen. In addition, there seems to be a 15-month diagnosis for each new patient .Taking this kind of information into account, it's no secret that work is going to be done but what is it that researchers have been able to find as a result of such work?
Lynda Chin, M.D., professor and chair of the Cancer Genome Atlas, spoke about the findings that came after a five-year scientific sojourn. There has been comprehensive data depicting how the sojourn in question has been able to lend credence to the idea of new data. Information on genetic mutations, deletions, and amplifications were all found and it is very telling, if you ask me. To me, it goes to show that there is more to be found in terms of creating stronger therapies in the long term.
It isn't, as if, there weren't mutated genes discovered in the past and organizations like Voices against Brain Cancer can tell you the same about the matter. Keep in mind that those involved in glioblastoma research have been able to see, according to the article, 61 new mutated genes. There have been strong cases of the epidermal growth factor receptor on chromosome 7. The fact that the EGFR gene is mutated in 57% of tumors only adds to the amount of information found at this point.
Considering all of the work that has been seen glioblastoma research so far, it's clear that these particular tumors have been given tremendous attention. They are some of the most complicated growths you can imagine and they are going to vary in many ways from one patient to the next. The ability to pinpoint certain genes, though, can lend a greater assist to the methods conducted in the way of research. My only hope is that this kind of information will make therapies in place even better.
About the Author:
Visit Voices Against Brain Cancer if you are searching for more information about glioblastoma research.
No comments:
Post a Comment